318 related articles for article (PubMed ID: 38275966)
1. Antivirals for Broader Coverage against Human Coronaviruses.
Outteridge M; Nunn CM; Devine K; Patel B; McLean GR
Viruses; 2024 Jan; 16(1):. PubMed ID: 38275966
[TBL] [Abstract][Full Text] [Related]
2. Current Strategies of Antiviral Drug Discovery for COVID-19.
Mei M; Tan X
Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
[TBL] [Abstract][Full Text] [Related]
3. Properties of Coronavirus and SARS-CoV-2.
Malik YA
Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
[TBL] [Abstract][Full Text] [Related]
4. Investigating theobromine as a potential anti-human coronaviral agent.
Li J; Wang Y; Rajpoot S; Lavrijsen M; Pan Q; Li P; Baig MS
Microbiol Immunol; 2023 Sep; 67(9):404-412. PubMed ID: 37415325
[TBL] [Abstract][Full Text] [Related]
5. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
Bchetnia M; Girard C; Duchaine C; Laprise C
J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
[TBL] [Abstract][Full Text] [Related]
6. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children.
Zimmermann P; Curtis N
Pediatr Infect Dis J; 2020 May; 39(5):355-368. PubMed ID: 32310621
[TBL] [Abstract][Full Text] [Related]
8. A low-background, fluorescent assay to evaluate inhibitors of diverse viral proteases.
Leonard RA; Rao VN; Bartlett A; Froggatt HM; Luftig MA; Heaton BE; Heaton NS
J Virol; 2023 Aug; 97(8):e0059723. PubMed ID: 37578235
[TBL] [Abstract][Full Text] [Related]
9. Genetic Surveillance of SARS-CoV-2 M
Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
[TBL] [Abstract][Full Text] [Related]
10. Emergence and Re-emergence of Human Coronaviruses: Spike Protein as the Potential Molecular Switch and Pharmaceutical Target.
Ahmad F; Kamal MA; Tekwani BL
Curr Pharm Des; 2021; 27(33):3566-3576. PubMed ID: 33327904
[TBL] [Abstract][Full Text] [Related]
11. Ocular tropism of coronavirus (CoVs): a comparison of the interaction between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-CoV-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye.
Al-Sharif E; Strianese D; AlMadhi NH; D'Aponte A; dell'Omo R; Di Benedetto R; Costagliola C
Int Ophthalmol; 2021 Jan; 41(1):349-362. PubMed ID: 32880786
[TBL] [Abstract][Full Text] [Related]
12. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
13. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.
Krishna G; Pillai VS; Veettil MV
Eur J Pharmacol; 2020 Oct; 885():173450. PubMed ID: 32739174
[TBL] [Abstract][Full Text] [Related]
14. Repurposing dyphylline as a pan-coronavirus antiviral therapy.
Wang Y; Rajpoot S; Li P; Lavrijsen M; Ma Z; Hirani N; Saqib U; Pan Q; Baig MS
Future Med Chem; 2022 May; 14(10):685-699. PubMed ID: 35387498
[No Abstract] [Full Text] [Related]
15. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
[TBL] [Abstract][Full Text] [Related]
16. Immunodetection assays for the quantification of seasonal common cold coronaviruses OC43, NL63, or 229E infection confirm nirmatrelvir as broad coronavirus inhibitor.
Weil T; Lawrenz J; Seidel A; Münch J; Müller JA
Antiviral Res; 2022 Jul; 203():105343. PubMed ID: 35598779
[TBL] [Abstract][Full Text] [Related]
17. The Nucleocapsid Proteins of SARS-CoV-2 and Its Close Relative Bat Coronavirus RaTG13 Are Capable of Inhibiting PKR- and RNase L-Mediated Antiviral Pathways.
LeBlanc K; Lynch J; Layne C; Vendramelli R; Sloan A; Tailor N; Deschambault Y; Zhang F; Kobasa D; Safronetz D; Xiang Y; Cao J
Microbiol Spectr; 2023 Jun; 11(3):e0099423. PubMed ID: 37154717
[TBL] [Abstract][Full Text] [Related]
18. Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography.
Wang J; Li D; Zhou Q; Wiltse A; Zand MS
Front Immunol; 2021; 12():696370. PubMed ID: 34386006
[TBL] [Abstract][Full Text] [Related]
19. An overview on the seven pathogenic human coronaviruses.
Kesheh MM; Hosseini P; Soltani S; Zandi M
Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
[TBL] [Abstract][Full Text] [Related]
20. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
